Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Guidant Corporation |
---|---|
Information provided by: | Guidant Corporation |
ClinicalTrials.gov Identifier: | NCT00180323 |
This prospective, randomized study will evaluate in patients, fulfilling implant criteria for Cardiac Resynchronisation Therapy (CRT) implant, the optimal atrial contribution to the resynchronised ventricles in the event of right atrial pacing.
Condition | Intervention | Phase |
---|---|---|
Dilated Cardiomyopathy |
Device: Renewal |
Phase IV |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Open Label, Dose Comparison, Parallel Assignment |
Official Title: | ACC - Atrial Contribution to CRT |
Estimated Enrollment: | 44 |
Study Start Date: | November 2004 |
Estimated Study Completion Date: | December 2008 |
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contact: Jesper Hastrup Svendsen, MD | + 45 35453545 |
Denmark | |
Rigshospitalet | Recruiting |
Copenhagen, Denmark | |
Contact: Jasper Hastrup Svendson, MD | |
Principal Investigator: Jasper Hastrup Svendson, MD |
Principal Investigator: | Jasper Hastrup Svendson, MD | Rigshospitalet, Copenhagen, Denmark |
Responsible Party: | Guidant Sweden ( Hakan Hornell ) |
Study ID Numbers: | ACC Version 1.1 11/09/2003 |
Study First Received: | September 12, 2005 |
Last Updated: | December 17, 2007 |
ClinicalTrials.gov Identifier: | NCT00180323 |
Health Authority: | Denmark: The Danish National Committee on Biomedical Research Ethics |
Heart Diseases Cardiomyopathy, Dilated Dilated cardiomyopathy Cardiomegaly Cardiomyopathies |
Cardiovascular Diseases |